Inspire Medical Systems adds AtriCure CEO Michael Carrel to board

Inspire Medical Systems, Inc. (NYSE: INSP) appointed Michael H. Carrel to its Board of Directors, effective July 20, according to a company statement.

Carrel has served as President, Chief Executive Officer, and a director of AtriCure, Inc. (NASDAQ: ATRC) since November 2012. During his tenure at AtriCure, the company's revenue grew from $82 million in 2013 to $535 million in 2025. He previously served as Chairman of the Board of Axonics, Inc. from 2019 through 2024, until its acquisition by Boston Scientific Corporation.

Carrel holds a B.S. in Accounting from Pennsylvania State University and an M.B.A. from the Wharton School of the University of Pennsylvania.

"We are pleased to welcome Mr. Carrel to our Board of Directors," said Tim Herbert, Chairman and Chief Executive Officer of Inspire Medical Systems. "Mike brings extensive executive leadership, board and medical device experience, including a strong track record of developing and commercializing minimally invasive therapies."

Inspire Medical Systems is a medical technology company focused on treatments for obstructive sleep apnea.

You May Also Be Interested In

• Entegris names Qorvo CEO to board, executive chair to retire
• Entegris Executive Chair Loy to retire, Gentilcore named board chair
• Northeast Indiana Bancorp declares $0.19 dividend, adds board member